日本要指導醫藥品「面對面販售原則」抗告訴訟【寰宇醫事裁判】 試閱
Procedure of Appeal about Face-to-Face Trading of the Medicine with Instructions in Japan
日本於2013年修正藥事法規定，一般用醫藥品的網路販售限制隨之解禁，惟在放寬用藥限制的同時，厚生勞動省也將「第一類醫藥品」中尚未確認安全性者指定為「要指導醫藥品」，該類藥品僅能透過店舖由藥劑師進行面對面販售。本件藥品販賣業者認為「面對面販售」規定已違反了憲法第22條第1項所保障之職業選擇自由，以及憲法第14條第1項之社會身分平等，遂向法院提起行政訴訟。
It is revised in the Pharmaceutical Affairs Law in 2013 in Japan that the general medicine could be allowed to sell on the internet. While loosing the restriction of medicine using, the Minister of Health, Labor and Welfares designated the medicine, whose safety haven’t been confirmed as the medicine with instructions, which could only be sold in the shops and by a pharmacist face to face. The medicine seller in this case insisted that the regulation of face-to-face trading had broken the freedom of career-choosing according to article 22 section 1 of Constitutional Law and Equality of Social Status according to article 14 section 1, and filed a administrative lawsuit.
141-148
